SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-12-000894
Filing Date
2012-03-09
Accepted
2012-03-09 16:47:34
Documents
10
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q peregrine_10q-013112.htm 10-Q 999378
2 CERTIFICATION peregrine_10q-ex3101.htm EX-31.1 11167
3 CERTIFICATION peregrine_10q-ex3102.htm EX-31.2 11046
4 CERTIFICATION peregrine_10q-ex32.htm EX-32 10335
  Complete submission text file 0001019687-12-000894.txt   3085660

Data Files

Seq Description Document Type Size
5 XBRL EXHIBIT pphm-20120131.xml EX-101.INS 414671
6 XBRL EXHIBIT pphm-20120131.xsd EX-101.SCH 17083
7 XBRL EXHIBIT pphm-20120131_cal.xml EX-101.CAL 28186
8 XBRL EXHIBIT pphm-20120131_def.xml EX-101.DEF 79521
9 XBRL EXHIBIT pphm-20120131_lab.xml EX-101.LAB 105720
10 XBRL EXHIBIT pphm-20120131_pre.xml EX-101.PRE 91919
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 12681198
SIC: 2834 Pharmaceutical Preparations